Workflow
每周股票复盘:鱼跃医疗(002223)研发投入5.4668亿元,推出多款国际先进水平产品

Core Viewpoint - Yuyue Medical emphasizes its commitment to innovation, quality, and social responsibility in its 2024 sustainability report, aiming to enhance product quality and efficiency while expanding into high-potential business areas [1][2]. Company Announcements - Yuyue Medical's R&D investment for 2024 reached 546.68 million RMB, accounting for 7.23% of its revenue [4]. - The company launched several internationally advanced products, including the Anytime 4 and Anytime 5 continuous glucose monitoring systems [4]. - Environmental protection investments totaled 482 million RMB, with the implementation of the ISO 14001 environmental management system [4]. - Charitable donations for 2024 amounted to 1.47 million RMB, supporting emergency medical services, diabetes patient assistance, and rural healthcare development projects [4]. Governance and ESG Management - Yuyue Medical has established a robust governance structure with committees for strategy, audit, nomination, and compensation to ensure effective decision-making [2]. - The company has developed a comprehensive ESG management system covering environmental, social, and governance aspects to ensure compliance and risk management [2]. - Yuyue Medical adheres to environmental laws and regulations, focusing on reducing greenhouse gas emissions and optimizing energy structure [2].